Tekla Life Sciences Investors Cash Flow Reinvestment Rate
Tekla Life Sciences Investors cash flow reinvestment rate. Tekla Life Sciences Investors (HQL) has a Cash Flow Reinvestment Rate of 0.00x as of March 2015, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $45.81K. Explore HQL operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Tekla Life Sciences Investors (2008–2013)
Cash flow reinvestment rate of Tekla Life Sciences Investors from 2008 to 2013. Historical reinvestment intensity for Tekla Life Sciences Investors across 6 annual periods. Also explore HQL shareholders equity momentum to track the company's year-over-year net asset growth rate.
Tekla Life Sciences Investors Cash Flow Reinvestment Rate by Year (2008–2013)
Tekla Life Sciences Investors cash flow reinvestment rate by year from 2008 to 2013. Year-by-year capital reinvestment analysis for Tekla Life Sciences Investors. For the full cash flow conversion analysis, see how efficiently does Tekla Life Sciences Investors generate cash.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2013 | 0.00x | $0.00 | $9.47K | $0.00 | — |
| 2012 | 0.00x | $0.00 | $21.11 Million | $0.00 | — |
| 2011 | 0.00x | $0.00 | $118.30 Million | $0.00 | — |
| 2010 | 0.00x | $0.00 | $1.90 Million | $0.00 | — |
| 2009 | 0.00x | $0.00 | $13.00 Million | $0.00 | — |
| 2008 | 0.00x | $0.00 | $11.80 Million | $0.00 | — |